A detailed history of Peak6 LLC transactions in Novartis Ag stock. As of the latest transaction made, Peak6 LLC holds 42,500 shares of NVS stock, worth $5.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
42,500
Previous 74,700 43.11%
Holding current value
$5.59 Million
Previous $9.04 Million 39.71%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$113.5 - $129.73 $1.53 Million - $1.75 Million
-13,474 Reduced 86.84%
2,042 $261,000
Q2 2025

Aug 13, 2025

BUY
$101.96 - $121.01 $1.58 Million - $1.88 Million
15,516 New
15,516 $1.88 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.